Rapisuwon, Suthee <br/><br/>
Exceptional response and multisystem autoimmune-like toxicities associated with the same T cell clone in a patient with uveal melanoma treated with immune checkpoint inhibitors.  [electronic resource] 

 -  Journal for immunotherapy of cancer  03 2019 
 - 61 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2051-1426 
<br/><br/><label>Standard No.: </label>10.1186/s40425-019-0533-0  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents, Immunological--adverse effects<br/>Bone Neoplasms--drug therapy<br/>CTLA-4 Antigen--antagonists & inhibitors<br/>Fatal Outcome<br/>Female<br/>Humans<br/>Ipilimumab--adverse effects<br/>Liver Neoplasms--drug therapy<br/>Lung Neoplasms--drug therapy<br/>Melanoma--drug therapy<br/>Middle Aged<br/>Nivolumab--adverse effects<br/>Programmed Cell Death 1 Receptor--antagonists & inhibitors<br/>Retinal Diseases--chemically induced<br/>T-Lymphocytes--immunology<br/>Uveal Neoplasms--drug therapy<br/>Uveomeningoencephalitic Syndrome--chemically induced<br/>Uveal Melanoma